Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

Although most individuals recover from acute SARS-CoV-2 infection, a significant number continue to suffer from Post-Acute Sequelae of SARS-CoV-2 (PASC), including the unexplained symptoms that are frequently referred to as long COVID, which could last for weeks, months, or even years after the acut...

Full description

Bibliographic Details
Main Authors: Hector Bonilla, Michael J. Peluso, Kathleen Rodgers, Judith A. Aberg, Thomas F. Patterson, Robert Tamburro, Lawrence Baizer, Jason D. Goldman, Nadine Rouphael, Amelia Deitchman, Jeffrey Fine, Paul Fontelo, Arthur Y. Kim, Gwendolyn Shaw, Jeran Stratford, Patricia Ceger, Maged M. Costantine, Liza Fisher, Lisa O’Brien, Christine Maughan, John G. Quigley, Vilma Gabbay, Sindhu Mohandas, David Williams, Grace A. McComsey
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-03-01
Series:Frontiers in Immunology
Subjects:
post-acute sequela of SARS-CoV-2 (PASC)
long COVID
SARS- CoV-2
long haulers
treatment
clinical trials
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2023.1129459/full

Similar Items

Similar Items